Form 4: Agilon Health Director Acquires Shares in Open Market Transaction

Silvana Battaglia, a director at Agilon Health, purchased 25,062 shares of common stock at a weighted average price of $2.0058 per share.

Summary

• On December 11, 2024, Silvana Battaglia, a director of Agilon Health, Inc., acquired 25,062 shares of the company's common stock.
• The shares were purchased at a weighted average price of $2.0058, with individual transactions ranging from $1.995 to $2.010 per share.
• Following this transaction, Ms. Battaglia's total holdings include 66,144 shares, which includes restricted stock units.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive as a director's purchase can be seen as a sign of confidence, but it's a routine transaction.

Positives

• A director's purchase of shares can be seen as a positive signal of confidence in the company's future prospects.

Industry Context

This transaction is a routine disclosure of insider trading activity and does not indicate any specific trend in the healthcare industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies, and this transaction is consistent with typical insider trading disclosures.
• The purchase of shares by a director is a common occurrence and does not deviate from industry norms.

Stakeholder Impact

• The share purchase may have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

Agilon Health, Director, Share Purchase, Insider Trading, Stock Acquisition, Form 4